Aesthetic PulseA serialised briefing for the UK aesthetics sector Published by Northbank Media
Subscription confirmed

You are on the list

You are subscribed to the Aesthetic Pulse briefing. One email per issue, and a note when a standing reference is revised.

What happens now

You are on the list. You will receive the briefing when a new issue is published, and a note when a standing reference is revised, with the date and what changed.

One email address, no name, no telephone number, and nothing passed to anyone. Sponsors never receive subscriber data in any form. You can unsubscribe from any email and we will delete the address on request.

Where to start

If you are new to the publication, the fastest route in is the format, which explains the seven section briefing rail, the analyst note and the confidence markers in about three minutes. After that, the standing reference on the regulatory landscape as it actually stands is the piece the issues lean on most.

Then read Issue 001, which is where the series starts and where most of the sector's arguments turn out to originate.

The deal, restated

We will not invent an event, a company, a person, a survey or a figure. We will not print a number we cannot trace. We will not rank or name businesses we have not assessed. And every forward looking line will tell you how confident we actually are.

If we break any of that, the contact page exists and corrections are answered first.

No commercial links on this page

This article contains no commercial links of any kind. No affiliate links, no sponsored placements, and no links to any clinic, practitioner, agency, brand, product or retailer. Nobody paid for it, nobody previewed it and nobody outside the editorial team saw it before publication.

This publication does not name, rank or rate clinics, practitioners or agencies, because it has assessed none of them. Our funding is set out in full on the about page, the sponsor position is on the sponsorship page, and our commitments are in our editorial standards.

This is trade analysis, not medical or legal advice.